Analysis Article • Jul 04
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedJul 16, 2026
DataAggregated Company Financials
Companies6
- 7D-0.9%
- 3M-27.6%
- 1Y-23.2%
- YTDn/a
Over the last 7 days, the Drug Retail industry has risen 2.0%, driven by gains from JD Health International of 0.5%. In contrast, the industry has lost 24% in the last 12 months. Looking forward, earnings are forecast to grow by 15% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 16 Jul 2026 | HK$193.2b | HK$143.1b | HK$8.7b | 30.2x | 22.2x | 1.4x |
| Sat, 13 Jun 2026 | HK$199.9b | HK$143.2b | HK$8.7b | 33.8x | 22.9x | 1.4x |
| Mon, 11 May 2026 | HK$248.3b | HK$140.9b | HK$8.7b | 43.8x | 28.7x | 1.8x |
| Wed, 08 Apr 2026 | HK$263.3b | HK$139.4b | HK$8.6b | 46.6x | 30.7x | 1.9x |
| Fri, 06 Mar 2026 | HK$264.0b | HK$129.8b | HK$7.0b | 36.7x | 38x | 2x |
| Sun, 01 Feb 2026 | HK$346.5b | HK$128.5b | HK$6.9b | 48.6x | 50.3x | 2.7x |
| Tue, 30 Dec 2025 | HK$301.9b | HK$126.9b | HK$6.8b | 38.7x | 44.4x | 2.4x |
| Thu, 27 Nov 2025 | HK$336.7b | HK$123.0b | HK$6.2b | 62.7x | 54.5x | 2.7x |
| Sat, 25 Oct 2025 | HK$335.6b | HK$122.1b | HK$6.1b | 61x | 54.7x | 2.7x |
| Mon, 22 Sep 2025 | HK$382.4b | HK$122.3b | HK$6.1b | 68.4x | 62.2x | 3.1x |
| Wed, 20 Aug 2025 | HK$346.8b | HK$121.0b | HK$5.1b | 55.7x | 68.1x | 2.9x |
| Fri, 18 Jul 2025 | HK$256.5b | HK$115.3b | HK$4.5b | 47.7x | 57x | 2.2x |
| Sun, 15 Jun 2025 | HK$230.0b | HK$115.3b | HK$4.5b | 47.3x | 51.1x | 2x |
| Tue, 13 May 2025 | HK$232.1b | HK$111.6b | HK$4.2b | 65x | 55.1x | 2.1x |
| Thu, 10 Apr 2025 | HK$186.8b | HK$109.0b | HK$4.1b | 53.4x | 45.4x | 1.7x |
| Sat, 08 Mar 2025 | HK$225.2b | HK$108.0b | HK$5.3b | 47.1x | 42.7x | 2.1x |
| Mon, 03 Feb 2025 | HK$178.0b | HK$104.4b | HK$3.6b | 40.6x | 49.3x | 1.7x |
| Wed, 01 Jan 2025 | HK$156.1b | HK$103.3b | HK$3.6b | 36.9x | 43.6x | 1.5x |
| Fri, 29 Nov 2024 | HK$167.9b | HK$104.3b | HK$3.6b | 38x | 46.5x | 1.6x |
| Sun, 27 Oct 2024 | HK$173.9b | HK$104.6b | HK$3.3b | 49x | 52.4x | 1.7x |
| Tue, 24 Sep 2024 | HK$147.5b | HK$105.9b | HK$3.4b | 39.8x | 43.9x | 1.4x |
| Thu, 22 Aug 2024 | HK$133.7b | HK$104.7b | HK$3.3b | 37x | 40.3x | 1.3x |
| Sat, 20 Jul 2024 | HK$137.5b | HK$101.8b | HK$2.4b | 42.2x | 57.6x | 1.3x |
| Mon, 17 Jun 2024 | HK$154.4b | HK$102.1b | HK$2.4b | 46.6x | 64.6x | 1.5x |
| Wed, 15 May 2024 | HK$169.0b | HK$103.6b | HK$2.3b | 50x | 72.7x | 1.6x |
| Fri, 12 Apr 2024 | HK$146.7b | HK$103.9b | HK$2.3b | 43.6x | 62.9x | 1.4x |
| Sun, 10 Mar 2024 | HK$162.1b | HK$105.2b | -HK$1,457,577,057.48 | 53.7x | -111.2x | 1.5x |
| Tue, 06 Feb 2024 | HK$147.9b | HK$106.2b | -HK$1,471,803,581.97 | 47.3x | -100.5x | 1.4x |
| Thu, 04 Jan 2024 | HK$196.1b | HK$105.6b | -HK$1,463,196,485.00 | 60.8x | -134x | 1.9x |
| Sat, 02 Dec 2023 | HK$202.1b | HK$105.8b | -HK$1,465,320,906.00 | 63.8x | -137.9x | 1.9x |
| Mon, 30 Oct 2023 | HK$205.0b | HK$101.7b | -HK$1,734,606,974.00 | 86x | -118.2x | 2x |
| Wed, 27 Sep 2023 | HK$224.4b | HK$102.3b | -HK$1,673,682,178.00 | 100.2x | -134.1x | 2.2x |
| Fri, 25 Aug 2023 | HK$228.7b | HK$102.7b | -HK$2,693,496,108.00 | 74.9x | -84.9x | 2.2x |
| Sun, 23 Jul 2023 | HK$270.4b | HK$96.2b | -HK$4,174,629,592.00 | 117.7x | -64.8x | 2.8x |
Price to Earnings Ratio
-64.8x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 21.9x which is lower than its 3-year average PE of 98.2x.
- The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.3x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 14% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | 0.62% | |
| Consumer Staples | 1.65% | |
| Food and Staples Retail | 1.64% | |
| Drug Retail | -0.93% | |
| Food Retail | 5.89% | |
| Big Box Super Stores | 4.30% | |
| Food Distributors | -3.03% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6618 JD Health International | HK$39.20 | 7.4% +HK$8.6b | -16.3% | PE20.1x | |
| 241 Alibaba Health Information Technology | HK$3.47 | 2.1% +HK$1.1b | -25.2% | PE25x | |
| 1833 Ping An Healthcare and Technology | HK$7.79 | 5.6% +HK$871.9m | -20.3% | PE37.7x | |
| 6086 Fangzhou | HK$0.85 | 18.1% +HK$180.1m | -78.0% | PE85.9x | |
| 2290 Lung Fung Group Holdings | HK$3.57 | 3.2% +HK$55.0m | n/a | PE10.5x |